Inventor · disambiguated record
Keith Canada
Also filed as: CANADA KEITH · CANADA KEITH A · CANADA KEITH ALLEN
23 granted patents·15 pending applications·235 citations·filing 2008–2024
95Inventor score
Files withBOEHRINGER INGELHEIM INT20CODEXIS INC8BARRETT RACHEL REBECCA4VAN RYN JOANNE4BOEHRINGER SOHN INGELHEIM1
Top patents by PatentIndex Score
38 records- 0196US8591900B2Anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2011·Granted Nov 26, 2013·53 cites·42 claims
- 0295US9090696B2Polynucleotides encoding anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2013·Granted Jul 28, 2015·33 cites·4 claims
- 0393US8486398B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2011·Granted Jul 16, 2013·27 cites·31 claims
- 0492US9023995B2Anti IL-36R antibodiesBOEHRINGER SOHN INGELHEIM·Filed 2012·Granted May 5, 2015·43 cites·36 claims
- 0592US8778346B2Anti-IL-23 antibodiesBARRETT RACHEL REBECCA·Filed 2011·Granted Jul 15, 2014·26 cites·46 claims
- 0689US11795445B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2021·Granted Oct 24, 2023·1 cites·12 claims
- 0788US9441036B2Anti-IL-23 antibodiesBARRETT RACHEL REBECCA·Filed 2014·Granted Sep 13, 2016·10 cites·14 claims
- 0887US11034948B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2019·Granted Jun 15, 2021·2 cites·24 claims
- 0987US9034822B2Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2013·Granted May 19, 2015·10 cites·9 claims
- 1087US8821871B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereofVAN RYN JOANNE·Filed 2012·Granted Sep 2, 2014·12 cites·19 claims
- 1186US12421509B2Engineered phosphopentomutase variant enzymesCODEXIS INC·Filed 2023·Granted Sep 23, 2025·0 cites·18 claims
- 1286US11242394B2Anti-CD40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Feb 8, 2022·3 cites·43 claims
- 1386US2025101093A1Anti-il-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1485US10550189B2Anti IL-36R antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Feb 4, 2020·6 cites·21 claims
- 1585US10202448B2Anti-IL-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Granted Feb 12, 2019·4 cites·9 claims
- 1684US2025027094A1Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2024·Application pending·0 cites
- 1784US2024409648A1Anti il-36r antibodiesBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1882US11162105B2Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2019·Granted Nov 2, 2021·1 cites·5 claims
- 1981US11795219B2Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 24, 2023·1 cites·38 claims
- 2079US2022153857A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2177US12480111B2Penicillin-G acylasesCODEXIS INC·Filed 2023·Granted Nov 25, 2025·0 cites·13 claims
- 2275US12110493B2Engineered purine nucleoside phosphorylase variant enzymesCODEXIS INC·Filed 2021·Granted Oct 8, 2024·0 cites·10 claims
- 2375US11028169B2Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jun 8, 2021·1 cites·67 claims
- 2474US10377804B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 13, 2019·1 cites·10 claims
- 2574US2024124581A1Antibody molecules for cancer treatmentBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 2672US2021198355A1Anti-il-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2770US2020231684A1Anti il-36r antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 2867US9840543B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 12, 2017·1 cites·15 claims
- 2965US11370818B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jun 28, 2022·0 cites·8 claims
- 3064US2019144534A1Anti-il-23 antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3161US11643642B2Penicillin-g acylasesCODEXIS INC·Filed 2018·Granted May 9, 2023·0 cites·6 claims
- 3261US2017058039A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 3360US2016222124A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 3457US2015315282A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3551US2014377265A1Anticoagulant antidotesVAN RYN JOANNE·Filed 2014·Application pending·0 cites
- 3647US2010310561A1Natriuretic fusion proteinsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 3746US2015210778A1Anticoagulant antidotesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3835US2012093814A1Fusion Proteins Comprising Canine FC PortionsCANADA KEITH·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →